Adjuvants, ImmunologicAntineoplastic AgentsChemotherapy, AdjuvantRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceFreund's AdjuvantRadiationCell Line, TumorDrug Screening Assays, AntitumorRadiation ProtectionRadiation MonitoringRadiotherapy, AdjuvantNeoplasmsDoxorubicinAdjuvants, PharmaceuticApoptosisDrug Resistance, NeoplasmBreast NeoplasmsCisplatinRadiation OncologyCombined Modality TherapyAntineoplastic Agents, PhytogenicCell SurvivalAntibiotics, AntineoplasticDrug Delivery SystemsCosmic RadiationGamma RaysRadiation Injuries, ExperimentalFluorouracilDrug CarriersTumor Cells, CulturedRadiotherapyRadiation PneumonitisXenograft Model Antitumor AssaysDNA DamageAntineoplastic Combined Chemotherapy ProtocolsMice, NudeRadiation-Sensitizing AgentsNeoplasms, Radiation-InducedCell ProliferationPaclitaxelBackground RadiationEllipticinesRadiotherapy DosageTreatment OutcomeEtoposideUltraviolet RaysDose-Response Relationship, DrugCamptothecinTime FactorsMice, Inbred BALB CRadiometryDrug Resistance, MultipleP-GlycoproteinInhibitory Concentration 50Molecular StructureRadiation EffectsColonic NeoplasmsDrug SynergismDrug DesignAntimetabolites, AntineoplasticCell CycleRadiation-Protective AgentsDisease-Free SurvivalNeoplasm StagingNeoplasm Recurrence, LocalAdenocarcinomaDNA Topoisomerases, Type IIAluminum HydroxideNanoparticlesGene Expression Regulation, NeoplasticTamoxifenProdrugsEnzyme InhibitorsDNA RepairOrganoplatinum CompoundsSurvival AnalysisDrug Evaluation, PreclinicalAntineoplastic Agents, AlkylatingPlant ExtractsClinical Trials as TopicTumor Suppressor Protein p53Brain NeoplasmsAcute Radiation SyndromeNanomedicineTopoisomerase I InhibitorsDaunorubicinCyclophosphamidePrognosisRadiotherapy, ConformalNeoplasm TransplantationPlatinumNeoplasms, ExperimentalMice, Inbred C57BLMitomycinSignal TransductionBrachytherapy